Additionally, a population of stem-like CD8+ T cells characterized by TCF1 expression persists in HCC and serves as a self-renewing source of effector T cells during PD-1 blockade, highlighting their relevance as therapeutic targets and biomarkers. Here, CD8A is linked to hepatocellular carcinoma.